Login to your account

Username *
Password *
Remember Me

The Use of Triple Therapy in Chronic Obstructive Pulmonary Disease and Outcomes of the IMPACT Trial

Q. What are the limitations of dual therapy in COPD?

I advocate the need to start treatment of COPD as soon as the diagnosis is made. LABA/LAMA (dual bronchodilation) should be

Epidemiology, Diagnosis and Available Treatment for Alpha 1 Antitrypsin Deficiency-related Emphysema in Europe

Highlights

  • Alpha 1 antitrypsin (AAT) deficiency (AATD) is a rare genetic risk factor that predisposes an individual to develop early-onset emphysema. It occurs most commonly in people of European heritage.
  • Accurate diagnosis of severe AATD, including

Non-invasive Screening of Expiratory Flow Limitation in Chronic Obstructive Pulmonary Disease

Take home messages

  • A hallmark of chronic obstructive pulmonary disease (COPD) is the occurrence of expiratory flow limitation (EFL) during a forced expiratory manoeuvre at lower expiratory flows compared with healthy subjects.

Challenges in Diagnosing and Treating Obstructive Sleep Apnoea in Children

The European Respiratory Society (ERS) taskforce on the diagnosis and management of obstructive sleep disordered breathing (SDB) in childhood, defined obstructive SDB as “a syndrome of upper airway dysfunction during sleep,

Foreword – European Respiratory & Pulmonary Diseases. 2018;4(1):13

Welcome to the summer edition of European Respiratory & Pulmonary Diseases. This journal describes current practices and recent advances that directly affect specialists in the diverse field of respiratory medicine, as

Recent Advances in Asthma Management

Q. What are the limitations of current reliever medications in mild asthma?

By far the most commonly used reliever medications in asthma are short-acting beta agonists (SABA) such as salbutamol and